EV Biologics Inc YECO
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.11
- Bid/Ask
- $0.00 / $0.06
- Shares Outstanding
- 10.23M
- Market Cap
- $1,022.54
- Volume/Avg
- 290 / 24,495
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
EV Biologics Inc enables EV Biologics to accelerate its nanotherapeutic biomanufacturing process and producer-cell line development through Lonza's infrastructure and deep expertise in cell and gene therapy. It has been developing nanotherapeutic-producing cells and optimizing a method for isolating cells from tissue, as well as expanding cell banks using defined cell culture conditions.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 284
- Website
- https://www.evbiologics.com
Valuation
|
Metric
|
YECO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
YECO
Financial Strength
|
Metric
|
YECO
|
|---|---|
Quick Ratio | 0.80 |
Current Ratio | 3.11 |
Interest Coverage | 1,393.93 |
Quick Ratio
YECO
Profitability
|
Metric
|
YECO
|
|---|---|
Return on Assets (Normalized) | 36.48% |
Return on Equity (Normalized) | 88.54% |
Return on Invested Capital (Normalized) | 58.97% |
Return on Assets
YECO
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|&h$k?Y | LOCK|d#V@ | $133B | |||
| Moderna Inc
MRNA
| LOCK|s?YB<f | LOCK|bv | $98B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|&zrk<# | LOCK|@W&> | $83B | |||
| argenx SE ADR
ARGX
| LOCK|#>l@F% | LOCK|%? | $56B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|&%>ByN& | LOCK|dDZ | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|&FB<?x | LOCK|>&NBQ | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|c<g$S>?t | LOCK|Jb<!> | $28B | |||
| Incyte Corp
INCY
| LOCK|#yHR%#< | LOCK|fr | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|PbkC<> | LOCK|Zz& | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|js&#PF | LOCK|^@ | $14B |
United States